167011-40-7

Basic information

• Product Name: (2R,3S)-3-amino-1-(isobutylamino)-4-phenyl-2-butanol
• Synonyms: (2R,3S)-3-amino-1-(isobutylamino)-4-phenyl-2-butanol
• CAS NO: 167011-40-7
• Molecular Weight: 236.357
• Mol File: 167011-40-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (2R,3S)-3-amino-1-(isobutylamino)-4-phenyl-2-butanol(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3S)-3-amino-1-(isobutylamino)-4-phenyl-2-butanol(167011-40-7)
• EPA Substance Registry System: (2R,3S)-3-amino-1-(isobutylamino)-4-phenyl-2-butanol(167011-40-7)

Safety Data

• Hazardous Substances Data: 167011-40-7(Hazardous Substances Data)

Upstream product

• 169331-42-4 βS--αR-<<(2-methylpropyl)amino>methyl>-benzenepropanol 
• 98760-08-8 (1-oxiranyl-2-phenylethyl)carbamic acid tert-butyl ester 
• 160232-08-6 (2R,3S)-3-tert-butoxycarbonylamino-1-isobutylamino-4-phenyl-2-butanol 

Downstream Products

• 854748-13-3 methyl 3-{[{(2R,3S)-2-hydroxy-3-[((2S)-3-methyl-2-{3-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-oxo-1-imidazolidinyl}butanoyl)amino]-4-phenylbutyl}(isobutyl)amino]sulfonyl}benzoate 
• 853894-09-4 (2S)-N-{(1S,2R)-1-benzyl-2-hydroxy-3-[{[3-(hydroxymethyl)phenyl]sulfonyl}(isobutyl)amino]propyl}-3-methyl-2-{3-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-oxo-1-imidazolidinyl}butanamide 
• 853894-01-6 (2S)-N-{(1S,2R)-1-benzyl-3-[[(4-cyanophenyl)sulfonyl](isobutyl)amino]-2-hydroxypropyl}-3-methyl-2-{3-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-oxo-1-imidazolidinyl}butanamide 
• 853894-04-9 (2S)-N-((1S,2R)-1-benzyl-2-hydroxy-3-{isobutyl[(4-vinylphenyl)sulfonyl]amino}propyl)-3-methyl-2-{3-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-oxo-1-imidazolidinyl}butanamide 
• 853894-05-0 (2S)-N-{(1S,2R)-1-benzyl-3-[[(4-formylphenyl)sulfonyl](isobutyl)amino]-2-hydroxypropyl}-3-methyl-2-{3-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-oxo-1-imidazolidinyl}butanamide 

Relevant articles and documents

A Practical Synthesis of an HIV Protease Inhibitor Intermediate - Diastreoselective Epoxide Formation from Chiral α-Aminoaldehydes

A practical and efficient synthesis of an HIV protease inhibitor intermediate has been developed based on the diastereoselective epoxide formation from a chiral α-aminoaldehyde and an in situ generated halomethyllithium reagent.